Ventripoint Diagnostics Ltd. (VPTDF)
- Previous Close
0.1781 - Open
0.1781 - Bid 0.1540 x --
- Ask 0.1712 x --
- Day's Range
0.1781 - 0.1781 - 52 Week Range
0.0982 - 0.2687 - Volume
5 - Avg. Volume
34,049 - Market Cap (intraday)
27.994M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date Aug 29, 2024 - Sep 3, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients. Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada.
ventripoint.comRecent News: VPTDF
Performance Overview: VPTDF
Trailing total returns as of 6/6/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VPTDF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VPTDF
Valuation Measures
Market Cap
25.26M
Enterprise Value
25.24M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
876.55
Price/Book (mrq)
--
Enterprise Value/Revenue
762.94
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-103.52%
Return on Equity (ttm)
-383.91%
Revenue (ttm)
45.29k
Net Income Avi to Common (ttm)
-4.72M
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
375.01k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-2M